| |
|
|
|
Catalyst Biosciences Inc.  
|
|
5.86 0 (0%) |
09-20 16:00 |
|
Open: |
5.84 |
Pre close: |
5.86 |
Target:
|
8.00 
|
|
High: |
6.0013 |
Low: |
5.785 |
Resistance:
|
6.85
7.51
|
|
Volume: |
43,595 |
Market Cap: |
70M |
Support:
|
5.78
4.81
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
6.00
|
MACD |
MACD(12,26):
|
-0.33 |
|
MA(20): |
6.26 |
Signal(12,26,9): |
-0.33  |
|
MA(100): |
7.61 |
Stochastic Oscillator |
%K(14,3):
|
8.12 |
|
MA(250): |
8.59 |
%D(3): |
9.55 |
|
Average Volume(K) |
3-Month: |
17593
|
52-Week |
High:
|
11.44 |
|
10-Days: |
5294 |
Low: |
5.78 |
|
RSI |
RSI(14):
|
33.61 |
Change(%): |
-42.4 |
|
Financials, Statistics and Valuation |
|
EPS |
-3.960 |
Return on Equity (ttm) |
-41.2 |
Shares Out. (M) |
12.02 |
|
EPS Est. Current Year |
-7.910 |
Return on Assets (ttm) |
-26.0 |
Shares Float (M) |
7.07 |
|
EPS Est. Next Year |
-4.810 |
PEG Ratio |
0.06 |
% Held by Insiders |
7.05 |
|
EPS Est. Next Quarter |
-1.550 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
72.91 |
|
Forward EPS |
-4.863 |
Gross Profit (p.s.) |
-1.786 |
Shares Short (K) |
447 |
|
Book Value (p.s.) |
7.750 |
EBITDA (p.s.) |
-4.149 |
P/E |
-1.48 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
0.76 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-42.46 |
P/S |
0.00 |
|
Operating Margin |
0.00 |
Levered Free Cash Flow
(M) |
-26.16 |
P/CF |
-1.66 |
|
|
|
|
|
|
